CIK 0000875320 · Large accelerated filer
VERTEX PHARMACEUTICALS INC / MA
Sign in to watch- Ticker
- VRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 043039129
- Phone
- 6173416393
- Business address
- 50 NORTHERN AVENUE, BOSTON, MA, 02210
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,307,135
- in 1 filing, $6.3M under 10b5-1 plans
Net −$6,307,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-24 | Sachdev Amit EVP Chief Patient & Ext Af Off | Shares withheld for taxes 10b5-1 | −1,518 | $485.11 | $736K | 57,416 |
| 2026-02-24 | McKechnie Duncan EVP, Chief Commercial Officer | Shares withheld for taxes 10b5-1 | −873 | $485.11 | $424K | 22,469 |
| 2026-02-24 | Kewalramani Reshma CEO & President | Shares withheld for taxes | −4,981 | $485.11 | $2.4M | 138,278 |
| 2026-02-24 | Bunnage Mark E. EVP, Chief Scientific Officer | Shares withheld for taxes 10b5-1 | −582 | $485.11 | $282K | 7,904 |
| 2026-02-24 | Bozic Carmen EVP and CMO | Shares withheld for taxes | −1,453 | $485.11 | $705K | 40,063 |
| 2026-02-24 | Biller Jonathan EVP and Chief Legal Officer | Shares withheld for taxes 10b5-1 | −1,144 | $485.11 | $555K | 14,604 |
| 2026-02-24 | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | Shares withheld for taxes 10b5-1 | −1,627 | $485.11 | $789K | 19,100 |
| 2026-02-24 | Ambrose Kristen SVP & Chief Accounting Officer | Shares withheld for taxes 10b5-1 | −546 | $485.11 | $265K | 7,204 |
| 2026-02-19 | Sachdev Amit EVP Chief Patient & Ext Af Off | Option exercise 10b5-1 | +23,479 | $155.57 | $3.7M | 92,521 |
| 2026-02-19 | Sachdev Amit EVP Chief Patient & Ext Af Off | Option exercise 10b5-1 | +25,026 | $187.53 | $4.7M | 117,547 |
| 2026-02-19 | Sachdev Amit EVP Chief Patient & Ext Af Off | Sale 10b5-1 | −920 | $463.91 | $427K | 116,627 |
| 2026-02-19 | Sachdev Amit EVP Chief Patient & Ext Af Off | Sale 10b5-1 | −2,730 | $465.05 | $1.3M | 113,897 |
| 2026-02-19 | Sachdev Amit EVP Chief Patient & Ext Af Off | Sale 10b5-1 | −1,848 | $465.80 | $861K | 112,049 |
| 2026-02-19 | Sachdev Amit EVP Chief Patient & Ext Af Off | Sale 10b5-1 | −10,263 | $467.75 | $4.8M | 101,786 |
| 2026-02-19 | Sachdev Amit EVP Chief Patient & Ext Af Off | Sale 10b5-1 | −19,662 | $468.57 | $9.2M | 82,124 |
| 2026-02-19 | Sachdev Amit EVP Chief Patient & Ext Af Off | Sale 10b5-1 | −7,241 | $469.61 | $3.4M | 74,883 |
| 2026-02-19 | Sachdev Amit EVP Chief Patient & Ext Af Off | Sale 10b5-1 | −11,712 | $470.54 | $5.5M | 63,171 |
| 2026-02-19 | Sachdev Amit EVP Chief Patient & Ext Af Off | Sale 10b5-1 | −4,237 | $471.43 | $2.0M | 58,934 |
| 2026-02-19 | Sachdev Amit EVP Chief Patient & Ext Af Off | Option exercise · Stock Option (Right to Buy) 10b5-1 | −23,479 | 0 | ||
| 2026-02-19 | Sachdev Amit EVP Chief Patient & Ext Af Off | Option exercise · Stock Option (Right to Buy) 10b5-1 | −25,026 | 0 |
Page 5 of 10 · 182 trades